Table 1 Result of the leave-one-out cross validation for 15 PD-associated genes from OMIM
From: Phenome-based gene discovery provides information about Parkinson’s disease drug targets
Gene | Rank | Percentage |
|---|---|---|
GBA | 15 | 0.08 % |
SNCA | 17 | 0.10 % |
MAPT | 18 | 0.10 % |
PLA2G6 | 20 | 0.11 % |
TBP | 23 | 0.13 % |
HTRA2 | 23 | 0.13 % |
PARK7 | 24 | 0.13 % |
LRRK2 | 24 | 0.13 % |
PARK2 | 24 | 0.13 % |
PINK1 | 26 | 0.15 % |
FBXO7 | 30 | 0.17 % |
GIGYF2 | 33 | 0.19 % |
SLC6A3 | 51 | 0.29 % |
EIF4G1 | 361 | 2.02 % |
VPS35 | 1521 | 8.53 % |